Arcus Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RCUS New York 2836 www.arcusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcus Biosciences, Inc.

Arcus Biosciences Presents First Postive Data for Oral Metastatic Kidney Cancer Treatment - Jul 1st, 2025 12:42 am
Arcus Biosciences Announces New Employment Inducement Grants - Jun 24th, 2025 2:35 pm
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response - Jun 1st, 2025 8:45 am
Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations - May 8th, 2025 4:19 am
Arcus Biosciences Inc (RCUS) Q1 2025 Earnings Call Highlights: Strategic Focus and Financial ... - May 7th, 2025 1:21 am
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates - May 6th, 2025 4:05 pm
Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update - May 6th, 2025 2:05 pm
Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting - Apr 23rd, 2025 2:05 pm
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update - Apr 22nd, 2025 2:05 pm
Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures - Mar 29th, 2025 7:44 am
Arcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last Month - Mar 14th, 2025 9:25 am
Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently - Mar 3rd, 2025 12:45 pm
Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares - Mar 2nd, 2025 5:26 am
Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Feb 28th, 2025 3:41 am
Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Feb 26th, 2025 2:35 pm
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates - Feb 25th, 2025 4:00 pm
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update - Feb 25th, 2025 2:05 pm
These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts - Feb 20th, 2025 4:23 am
Arcus says new data demonstrated ‘best-in-class potential’ for casdatifan - Feb 18th, 2025 6:40 am
Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering - Feb 18th, 2025 4:57 am